Effect of Ramosetron on Bowel Motility After Colorectal Resection

• Status: Unknown status
• Trial end date: 2011-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Ramosetron is effective in preventing postoperative nausea and vomiting. Several studies reported that ramosetron is also effective treatment diarrhea-predominant irritable bowel syndrome. The investigators examine the effect of ramosetron used for preventing postoperative nausea and vomiting on bowel motility.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Kyunghee University Medical Center
• Treatments: Ramosetron

Criteria

Inclusion Criteria:

• 20-70 yr of age,

• ASA I or II,

• scheduled for laparoscopic colorectal surgery

Exclusion Criteria:

• antiemetic use within 24hr prior to surgery

• steroid use within 24hr prior to surgery or 48hr after surgery

• insulin dependent DM

• cardiovascular or pulmonary disease

• renal or hepatic insufficiency

• BMI >=35kg/m2

• pregnancy